Loading...
Aptus Pharma Ltd. IPO Details – Price, Date, GMP & Analysis
Listed
SME
Price Range:
Rs.70.00
Issue Size:
Rs.13.02 Cr
Lot Size:
2000 shares
Open Date:
September 23
Aptus Pharma Ltd. IPO Overview
Bidding Dates
September 23 - September 25
Min Investment
₹140,000
Price Range
₹70.00
Issue Size
₹13.02 Cr
IPO DRHP Doc
Company Overview
Aptus Pharma Ltd, incorporated in 2010, specializes in marketing and distributing pharmaceutical formulations across various therapeutic areas. The company offers 194 formulations and operates warehouses in Ahmedabad, Gujarat, supported by a distribution network of 125 distributors and a sales team of 54 personnel. As of March 31, 2025, it employed 70 people.
IPO Timeline
Opens
Sep 23
Closes
Sep 25
Allotment
Sep 26
Refunds
Sep 29
Shares Credit
Sep 29
Listing
Sep 30
Opens
Sep 23
Closes
Sep 25
Allotment
Sep 26
Refunds
Sep 29
Shares Credit
Sep 29
Listing
Sep 30
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 1.24x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 28.75x | Oversubscribed |
| RII (Retail Individual Investors) | 31.43x | Oversubscribed |
| Total Subscription | 22.27x | Oversubscribed |
Last updated: Sep 25, 2025, 05:06 PM
Current GMP:
Rs.4
Est. Listing:
Rs.74
Est. Gain:
+5.7%
Star Rating:
★★★★★(0/5)
Financial Information
Financial Data Table
Detailed breakdown of financial metrics across years
| Financial Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | ₹21.92 Cr | ₹10.03 Cr | ₹6.22 Cr |
| EBITDA | ₹4.76 Cr | ₹1.49 Cr | ₹0.57 Cr |
| Net Worth | ₹6.97 Cr | ₹1.77 Cr | ₹0.97 Cr |
| Profit After Tax | ₹3.1 Cr | ₹0.8 Cr | ₹0.19 Cr |
| Reserves and Surplus | ₹1.97 Cr | ₹1.47 Cr | ₹0.67 Cr |
| Total Borrowing | ₹10.36 Cr | ₹5.31 Cr | ₹2.21 Cr |
| Total Income | ₹24.64 Cr | ₹17.88 Cr | ₹13.9 Cr |
Financial data is visualized in the chart above
Strengths & Risks Analysis
Key Strengths
Competitive advantages and positive aspects
- Established presence in pharmaceutical marketing and distribution since 2010
- Diverse product portfolio across multiple therapeutic categories and dosage forms
- Partnership network with seven manufacturing units providing operational flexibility
- Experienced promoter group with pharmaceutical industry expertise
IPO Details
Aptus Pharma IPO Details
| Face Value | ₹10 per share |
| IPO Date | September 23, 2025 to September 25, 2025 |
| Issue Price Band | ₹65 to ₹70 per share |
| Issue Price Final | ₹70 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Listing Date | September 30, 2025 |
| Lot Size | 2,000 Shares |
| Net Offered to Public | 17,66,000 shares (aggregating up to ₹12.36 Cr) |
| Reserved for Market Maker | 94,000 shares (aggregating up to ₹0.6580 Cr)Market-Hub Stock Broking Pvt.Ltd. |
| Sale Type | Fresh Capital |
| Share Holding Post Issue | 68,60,000 shares |
| Share Holding Pre Issue | 50,00,000 shares |
| Total Issue Size | 18,60,000 shares (aggregating up to ₹13.02 Cr) |
Aptus Pharma IPO Reservation
Share Reservation Distribution
QIB
880,000 shares (47.31%)
Retail
620,000 shares (33.33%)
Anchor Investors
528,000 shares (28.39%)
QIB (Ex-Anchor)
352,000 shares (18.92%)
HNI (NII)
266,000 shares (14.3%)
bNII (>₹10L)
178,000 shares (9.57%)
Market Maker
94,000 shares (5.05%)
sNII (<₹10L)
88,000 shares (4.73%)
Aptus Pharma IPO Promoter Holding
| Promoter Holding Post Issue | 72.89% |
| Promoter Holding Pre Issue | 100% |
Aptus Pharma IPO Listing Details
| BSE Listing Group | MT (Trade to Trade) |
| BSE Script Code | 544529 |
| Final Issue Price | ₹70 per share |
| ISIN | INE15XJ01010 |
| Listing Date | September 30, 2025 |
| NSE Symbol |
Key Dates
Open Date:September 23
Close Date:September 25
Listing Date:September 30
